IMR was lower in the combination group than in the IC abciximab group ( 23.57.4 U vs. 66.948.7 U , p = 0.001 ) and tended to be lower than in the AT group , with barely missed significance ( 23.57.4 U vs. 37.226.1 U , p = 0.07 ) .